Albert Holvast

804 total citations
9 papers, 554 citations indexed

About

Albert Holvast is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Albert Holvast has authored 9 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Rheumatology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Albert Holvast's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Systemic Lupus Erythematosus Research (4 papers) and T-cell and B-cell Immunology (3 papers). Albert Holvast is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Systemic Lupus Erythematosus Research (4 papers) and T-cell and B-cell Immunology (3 papers). Albert Holvast collaborates with scholars based in Netherlands, Belgium and United States. Albert Holvast's co-authors include C. A. Benne, Marc Bijl, Sander van Assen, Johanna Westra, Cees G. M. Kallenberg, Aalzen de Haan, M. A. van Leeuwen, Marlies Blom, Alexandre E. Voskuyl and Marcel D. Posthumus and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Clinical Immunology.

In The Last Decade

Albert Holvast

8 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Holvast Netherlands 8 263 256 134 126 106 9 554
Irena Litinsky Israel 12 243 0.9× 372 1.5× 121 0.9× 129 1.0× 92 0.9× 21 651
Huei-Huang Ho Taiwan 13 235 0.9× 400 1.6× 271 2.0× 37 0.3× 74 0.7× 23 696
Lillemor Skattum Sweden 16 575 2.2× 196 0.8× 136 1.0× 57 0.5× 97 0.9× 40 852
Lieh-Bang Liou Taiwan 12 153 0.6× 272 1.1× 233 1.7× 41 0.3× 62 0.6× 34 550
Marlies Blom Netherlands 5 136 0.5× 205 0.8× 39 0.3× 94 0.7× 67 0.6× 5 400
Gordon K. Lam United States 9 203 0.8× 282 1.1× 58 0.4× 109 0.9× 30 0.3× 12 587
Reem Abdwani Oman 12 351 1.3× 328 1.3× 52 0.4× 80 0.6× 20 0.2× 39 665
Ruth Fernandez‐Ruiz United States 11 251 1.0× 295 1.2× 42 0.3× 50 0.4× 106 1.0× 22 545
V. Veit France 14 113 0.4× 208 0.8× 142 1.1× 23 0.2× 63 0.6× 40 606
Kristján Erlendsson Iceland 10 281 1.1× 152 0.6× 57 0.4× 46 0.4× 59 0.6× 17 431

Countries citing papers authored by Albert Holvast

Since Specialization
Citations

This map shows the geographic impact of Albert Holvast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Holvast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Holvast more than expected).

Fields of papers citing papers by Albert Holvast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Holvast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Holvast. The network helps show where Albert Holvast may publish in the future.

Co-authorship network of co-authors of Albert Holvast

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Holvast. A scholar is included among the top collaborators of Albert Holvast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Holvast. Albert Holvast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Assen, Sander van, Aalzen de Haan, Albert Holvast, et al.. (2011). Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency. Clinical Immunology. 141(2). 161–168. 22 indexed citations
2.
Assen, Sander van, Albert Holvast, Denise Telgt, et al.. (2010). Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. Clinical Immunology. 136(2). 228–235. 22 indexed citations
3.
Holvast, Albert, Aalzen de Haan, Sander van Assen, et al.. (2009). Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis. Annals of the Rheumatic Diseases. 69(5). 924–927. 14 indexed citations
4.
Assen, Sander van, Albert Holvast, C. A. Benne, et al.. (2009). Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis & Rheumatism. 62(1). 75–81. 259 indexed citations
5.
Holvast, Albert, Sander van Assen, Anke Huckriede, et al.. (2009). Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Lara D. Veeken. 48(10). 1294–1299. 30 indexed citations
6.
Holvast, Albert, Sander van Assen, Aalzen de Haan, et al.. (2009). Studies of cell‐mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis & Rheumatism. 60(8). 2438–2447. 42 indexed citations
7.
Holvast, Albert, Sander van Assen, Aalzen de Haan, et al.. (2008). Antibody and cell-mediated responses to influenza vaccination in patients with systemic lupus erythematosus and, healthy controls. Data Archiving and Networked Services (DANS). 58(9).
8.
Holvast, Albert, Coen A. Stegeman, C. A. Benne, et al.. (2008). Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination. Annals of the Rheumatic Diseases. 68(6). 873–878. 52 indexed citations
9.
Holvast, Albert, et al.. (2005). Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Annals of the Rheumatic Diseases. 65(7). 913–918. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irena Litinsky Breakdown of academic impact, for papers by Huei-Huang Ho Breakdown of academic impact, for papers by Lillemor Skattum Breakdown of academic impact, for papers by Lieh-Bang Liou Breakdown of academic impact, for papers by Marlies Blom Breakdown of academic impact, for papers by Gordon K. Lam Breakdown of academic impact, for papers by Reem Abdwani Breakdown of academic impact, for papers by Ruth Fernandez‐Ruiz Breakdown of academic impact, for papers by V. Veit Breakdown of academic impact, for papers by Kristján Erlendsson
Rankless by CCL
2026